Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–57 of 57
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.5y ago· Nov 15, 2024
17 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$15K-$50K
Trade dateOct 29, 2024
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−62.8% vs S&P 500
Trade dateMay 8, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Pfizer
PFE
$15K-$50K
+42.5% vs S&P 500
Trade dateMay 3, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+32.4% vs S&P 500
Trade dateMay 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
40 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+49.7% vs S&P 500
Trade dateApr 5, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
41 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+58.9% vs S&P 500
Trade dateApr 4, 2024
Regeneron Pharmaceuticals, Inc. -
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−24.9% vs S&P 500
Trade dateApr 3, 2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↑bought
AbbVie
ABBV
$1K-$15K
−25.4% vs S&P 500
Trade dateApr 3, 2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−46.5% vs S&P 500
Trade dateApr 3, 2024
Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+23.5% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+24.9% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.2y ago· Mar 15, 2024
17 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−40.4% vs S&P 500
Trade dateFeb 27, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Novo Nordisk
NVO
$15K-$50K
+109.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.2% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+40.0% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.5y ago· Dec 15, 2023
25 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+61.9% vs S&P 500
Trade dateNov 20, 2023
Option⚑ Pharmaceutical
Filed 2.5y ago· Dec 15, 2023
29 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+61.9% vs S&P 500
Trade dateNov 16, 2023
Option⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
30 days to discloseTommy Tuberville
RSenateAlabama
↑bought
AbbVie
ABBV
$1K-$15K
−30.5% vs S&P 500
Trade dateOct 17, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
30 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−16.1% vs S&P 500
Trade dateOct 17, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Merck
MRK
$1K-$15K
+13.2% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
GSK PLC
GSK
$1K-$15K
+14.9% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+19.3% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 13, 2023
35 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
⚑ Pharmaceutical
Filed 2.8y ago· Aug 14, 2023
20 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−83.9% vs S&P 500
Trade dateJul 25, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.9y ago· Jul 14, 2023
32 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−96.9% vs S&P 500
Trade dateJun 12, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 3.1y ago· May 12, 2023
39 days to discloseTommy Tuberville
RSenateAlabama
↑bought
GSK PLC
GSK
$1K-$15K
−22.3% vs S&P 500
Trade dateApr 3, 2023
⚑ Pharmaceutical
Filed 3.1y ago· May 12, 2023
39 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−82.8% vs S&P 500
Trade dateApr 3, 2023
Regeneron Pharmaceuticals, Inc. -
⚑ Pharmaceutical
Filed 3.1y ago· May 12, 2023
39 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+13.4% vs S&P 500
Trade dateApr 3, 2023
⚑ Pharmaceutical
Filed 3.1y ago· May 11, 2023
38 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+13.4% vs S&P 500
Trade dateApr 3, 2023
⚑ Pharmaceutical
Filed 3.1y ago· May 11, 2023
38 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−82.8% vs S&P 500
Trade dateApr 3, 2023
Regeneron Pharmaceuticals, Inc. -
⚑ Pharmaceutical
Filed 3.1y ago· May 11, 2023
38 days to discloseTommy Tuberville
RSenateAlabama
↑bought
GSK PLC
GSK
$1K-$15K
−22.3% vs S&P 500
Trade dateApr 3, 2023
⚑ Pharmaceutical
Filed 3.6y ago· Nov 10, 2022
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Amgen
AMGN
$1K-$15K
+15.5% vs S&P 500
Trade dateOct 6, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Nov 10, 2022
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−47.2% vs S&P 500
Trade dateOct 6, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Nov 10, 2022
36 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Zoetis
ZTS
$1K-$15K
+113.7% vs S&P 500
Trade dateOct 5, 2022
⚑ Pharmaceutical
Filed 4.2y ago· Apr 8, 2022
9 days to discloseTommy Tuberville
RSenateAlabama
↑bought
AbbVie
ABBV
$1K-$15K
−34.3% vs S&P 500
Trade dateMar 30, 2022
⚑ Pharmaceutical
Filed 4.2y ago· Apr 8, 2022
9 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Merck
MRK
$1K-$15K
−19.8% vs S&P 500
Trade dateMar 30, 2022
⚑ Pharmaceutical
Filed 4.2y ago· Apr 8, 2022
9 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+47.1% vs S&P 500
Trade dateMar 30, 2022
Regeneron Pharmaceuticals, Inc. -
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
24 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+12.4% vs S&P 500
Trade dateJan 21, 2022
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
−208.5% vs S&P 500
Trade dateJan 14, 2022
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
32 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−27.7% vs S&P 500
Trade dateJan 13, 2022
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
33 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Amgen
AMGN
$1K-$15K
−2.9% vs S&P 500
Trade dateJan 12, 2022
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
33 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−103.9% vs S&P 500
Trade dateJan 12, 2022
Pfizer, Inc.
⚑ Pharmaceutical
Filed 4.6y ago· Oct 15, 2021
15 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+28.0% vs S&P 500
Trade dateSep 30, 2021
⚑ Pharmaceutical
Filed 4.8y ago· Aug 13, 2021
28 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateJul 16, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 23, 2021
116 days to disclose · 71 past 45-day windowTommy Tuberville
RSenateAlabama
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
Trade dateMar 29, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 23, 2021
116 days to disclose · 71 past 45-day windowTommy Tuberville
RSenateAlabama
↓sold
Merck
MRK
$1K-$15K
Trade dateMar 29, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 23, 2021
116 days to disclose · 71 past 45-day windowTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 29, 2021
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 15, 2024 1.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 29, 2024 17 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Missed gain·−$8.1K-100.9% −62.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Smart sell·+$947+2.9% +42.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Vertex Pharmaceuticals VRTX ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Missed gain·−$583-7.3% +32.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 5, 2024 40 days to disclose | Good buy·+$7K+87.4% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Regeneron Pharmaceuticals REGN Regeneron Pharmaceuticals, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 4, 2024 41 days to disclose | Smart sell·+$1.6K+19.8% +58.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$1K+12.5% −24.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$965+12.1% −25.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$6.7K-83.9% −46.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$1K-12.5% +24.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 15, 2024 2.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 27, 2024 17 days to disclose | Flat·+0.4% −40.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Smart sell·+$20K+61.5% +109.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Missed gain·−$981-12.3% +40.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 20, 2023 25 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 16, 2023 29 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Good buy·+$2.7K+33.2% −30.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Bad buy·−$220-2.7% −16.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Flat·+0.0% +13.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.9K-48.8% +14.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.6K-44.4% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2023 2.8y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jul 25, 2023 20 days to disclose | Bad buy·−$2.2K-27.1% −83.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2023 2.9y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jun 12, 2023 32 days to disclose | Bad buy·−$2.6K-32.3% −96.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 39 days to disclose | Good buy·+$4.1K+51.4% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Regeneron Pharmaceuticals REGN Regeneron Pharmaceuticals, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 39 days to disclose | Bad buy·−$723-9.0% −82.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 39 days to disclose | Flat·+0.0% +13.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 11, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 38 days to disclose | Flat·+0.0% +13.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 11, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Regeneron Pharmaceuticals REGN Regeneron Pharmaceuticals, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 38 days to disclose | Bad buy·−$723-9.0% −82.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 11, 2023 3.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 38 days to disclose | Good buy·+$4.1K+51.4% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 6, 2022 35 days to disclose | Good buy·+$2.7K+34.1% +15.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Vertex Pharmaceuticals VRTX ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 6, 2022 35 days to disclose | Good buy·+$3.5K+44.1% −47.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 5, 2022 36 days to disclose | Smart sell·+$2K+24.4% +113.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2022 4.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 30, 2022 9 days to disclose | Good buy·+$1.7K+21.3% −34.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2022 4.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 30, 2022 9 days to disclose | Good buy·+$2.9K+35.8% −19.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2022 4.2y ago | Tommy Tuberville RSenateAlabama | ↓sold | Regeneron Pharmaceuticals REGN Regeneron Pharmaceuticals, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 30, 2022 9 days to disclose | Missed gain·−$684-8.5% +47.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 21, 2022 24 days to disclose | Missed gain·−$4K-50.6% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 14, 2022 31 days to disclose | Missed gain·−$85.2K-262.1% −208.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 13, 2022 32 days to disclose | Missed gain·−$6.5K-81.4% −27.7% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 12, 2022 33 days to disclose | Good buy·+$3.9K+48.7% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 12, 2022 33 days to disclose | Bad buy·−$4.2K-52.3% −103.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 15, 2021 4.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 30, 2021 15 days to disclose | Good buy·+$3.6K+44.7% +28.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2021 4.8y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jul 16, 2021 28 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Jul 23, 2021 4.9y ago | Tommy Tuberville RSenateAlabama | ↑bought | Regeneron Pharmaceuticals REGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 29, 2021 116 days to disclose · 71 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 23, 2021 4.9y ago | Tommy Tuberville RSenateAlabama | ↓sold | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 29, 2021 116 days to disclose · 71 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 23, 2021 4.9y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 29, 2021 116 days to disclose · 71 past 45-day window | price pending | $1K-$15K midpoint $8K |